Dopaminergic regulation of gonadotropin levels and pulsatility in normal women
- PMID: 2951277
Dopaminergic regulation of gonadotropin levels and pulsatility in normal women
Abstract
This study was done to define the concentration of dopamine (DA) that inhibits gonadotropin secretion and to study the effect of DA D-2 receptor blockade during the infusions. Normal women received 5-hour infusions of either glucose (n = 14) or DA at rates of 0.04 (n = 6), 0.4 (n = 6), and 4.0 micrograms/kg X minute (n = 9). After 3 hours, metoclopramide (MTC) was administered. Mean serum luteinizing hormone (LH) concentration declined during 0.4 (P less than 0.01) and 4.0 micrograms/kg X minute (P less than 0.05) infusion doses of DA. This effect of DA was not consistently (P greater than 0.05) antagonized by MTC. Six women received DA (4.0 micrograms/kg X minute) or glucose for 18 hours. After 17 hours, MTC was given. Blood samples were collected every 10 minutes during the last 8 hours. No significant effect on LH pulse frequency and pulse amplitude was observed (P greater than 0.05). A marked (P less than 0.01) rise in LH occurred after MTC administration. The authors conclude that (1) physiologic doses of DA may inhibit LH secretion with only little, if any, effect on the pulsatile release; and (2) low-affinity DA receptors responsive to DA D-2 antagonists may regulate LH secretion.
Similar articles
-
Dopaminergic inhibition of glycoprotein hormone alpha-subunit in normal subjects.Metabolism. 1991 Feb;40(2):150-4. doi: 10.1016/0026-0495(91)90166-t. Metabolism. 1991. PMID: 1671164
-
Effects of dopaminergic blockade on the sleep-associated changes of luteinizing hormone pulsatility in early follicular phase women.Neuroendocrinology. 1988 Dec;48(6):634-9. doi: 10.1159/000125074. Neuroendocrinology. 1988. PMID: 3251162 Clinical Trial.
-
Increased dopaminergic activity inhibits basal and metoclopramide-stimulated prolactin and thyrotropin secretion.J Clin Endocrinol Metab. 1986 Apr;62(4):778-82. doi: 10.1210/jcem-62-4-778. J Clin Endocrinol Metab. 1986. PMID: 3949956
-
Dopaminergic inhibition of pulsatile luteinizing hormone secretion is abnormal in regularly menstruating women with insulin-dependent diabetes mellitus.Fertil Steril. 1995 Aug;64(2):279-84. Fertil Steril. 1995. PMID: 7615103 Clinical Trial.
-
Effects of dopamine and metoclopramide in polycystic ovary syndrome.J Clin Endocrinol Metab. 1986 Aug;63(2):506-9. doi: 10.1210/jcem-63-2-506. J Clin Endocrinol Metab. 1986. PMID: 3722335
Cited by
-
Effects of Anesthetic Agent Propofol on Postoperative Sex Hormone Levels.Geburtshilfe Frauenheilkd. 2016 Apr;76(4):408-412. doi: 10.1055/s-0041-111571. Geburtshilfe Frauenheilkd. 2016. PMID: 27134297 Free PMC article.
-
The mechanism of the effect of combination treatment with clomiphene and bromocriptine in patients with normoprolactinemic anovulation.J Endocrinol Invest. 1990 Jul-Aug;13(7):549-54. doi: 10.1007/BF03348623. J Endocrinol Invest. 1990. PMID: 2121818 Clinical Trial.
-
Assessment of the luteal phase in stimulated and substituted cycles.Facts Views Vis Obgyn. 2009;1(1):30-46. Facts Views Vis Obgyn. 2009. PMID: 25478069 Free PMC article. No abstract available.
-
Lack of effect of the dopamine D1 antagonist, NNC 01-0687, on unstimulated and stimulated release of anterior pituitary hormones in males.J Endocrinol Invest. 1998 May;21(5):291-7. doi: 10.1007/BF03350331. J Endocrinol Invest. 1998. PMID: 9648050 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources